Thursday, May 03, 2012
“The Department of Diagnostic Radiology and Nuclear Medicine is an outstanding leader in the growth and expansion of our research, patient care and educational enterprises here at the University of Maryland,” says Dean Reece, who is also vice president for medical affairs of the University of Maryland. “Its distinguished faculty physicians employ cutting edge technology to provide the many departments and specialties within our medical school with unparalleled radiology expertise, helping to diagnose and treat patients across the spectrum of disease. The department’s robust research enterprise is exploring the next generation in imaging technology and techniques. Dr. Melhem is a brilliant physician-scientist with an innovative vision of how academic radiology will be practiced in the future. I am certain that with his very strong record of academic accomplishments along with his collaborative style and strong interpersonal skills, he will be able to effectively lead this large department to the next level of excellence and strengthen its position as a national leader in its field.”
Dr. Melhem will join the University of Maryland School of Medicine from the
“The Department of Radiology and Nuclear Medicine is an integral component of patient care at the
Dr. Melhem will assume the leadership of the Department of Radiology and Nuclear Medicine from interim chair William F. Regine, M.D., who also serves as the professor and Isadore & Fannie Schneider Foxman Endowed Chairman of the Department of Radiation Oncology. “I offer my sincere thanks to Dr. Regine for his excellent leadership of the department during his time as interim chair,” says Dean Reece.
“I look forward to being a part of the
Joining Dr. Melhem at the
Dr. Elias Melhem directs a robust research program that has held significant National Institutes of Health funding throughout his career. He has held nearly $10 million in external research funding, from the NIH to support his research program. His research focuses in part on brain function in children with sickle cell disease. His laboratory has used techniques such as functional magnetic resonance imaging (fMRI) to discover that sickle cell causes progressive cognitive impairment in such children. His laboratory also examines changes in vascular reactivity to examine how tumors transform from benign to malignant, in hopes of finding early indicators for this malignant transformation. His team also uses advanced MRI techniques to evaluate upper motor neuron disease in patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
Dr. Melhem hopes to continue his own research at the
He received his M.D. from the University of South Alabama School of Medicine in 1988; an internship and residency in pediatrics at the
Dr. Melhem began working at
Dr. Melhem is a distinguished and highly regarded physician and scientist and has received many honors, including being named the Melvin M. Figley Fellow in Radiology Journalism from the American Roentgen Ray Society, serving as an examiner for the American Board of Radiology, a member of the editorial board for the journal Radiology and a member of the editorial board for the American Journal of Roentgenology. He also has served as a member of the Board of Scientific Counselors for the
“Dr. Melhem has led a distinguished and accomplished career, and I am certain that he will elevate our department to new heights,” says Dean Reece.